SG3 Management, LLC - BEAM THERAPEUTICS INC ownership

BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 236 filers reported holding BEAM THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.67 and the average weighting 0.4%.

Quarter-by-quarter ownership
SG3 Management, LLC ownership history of BEAM THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$31,288
-96.7%
800
-96.0%
0.01%
-92.3%
Q3 2022$952,400
+3.9%
20,000
+25.0%
0.06%
+150.0%
Q1 2022$917,000
-71.2%
16,000
-60.0%
0.03%
-59.4%
Q4 2021$3,188,000
-63.0%
40,000
-40.3%
0.06%
-79.1%
Q2 2021$8,624,000
-43.9%
67,000
-65.1%
0.31%
-20.3%
Q1 2021$15,368,000192,0000.38%
Other shareholders
BEAM THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
MWG Management Ltd. 2,362,635$304,095,00029.88%
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO 224,391$28,881,00022.15%
HSG Holding Ltd 796,089$102,465,0007.14%
DC Investments Management, LLC 21,010$2,704,0006.36%
PATHWAY CAPITAL MANAGEMENT, LP 112,197$14,441,0005.74%
Redmile Group, LLC 2,052,506$264,178,0003.91%
Casdin Capital, LLC 818,820$105,390,0002.68%
Darwin Global Management, Ltd. 126,985$16,344,0002.64%
Evolutionary Tree Capital Management, LLC 44,032$5,667,0002.61%
HHLR ADVISORS, LTD. 1,845,753$237,567,0002.44%
View complete list of BEAM THERAPEUTICS INC shareholders